“Advocacy work is continuing to ensure pharmacy’s value, potential and needs are factored into healthcare policy discussions at the highest levels,” writes Community Pharmacy England Chief Executive Janet Morrison in a new blog. In-depth analysis of critical funding issues, national media work, and implementation of service changes continued over the summer alongside Community Pharmacy England’s
Read moreThe Drug Tariff Category M pricelist for October 2025 has been published on the NHS Business Services Authority (NHSBSA) website. At the end of Q4 2024/25 there remains an over delivery of medicine margin of circa £124m. Based on analysis of the Category M price list for October 2025, Community Pharmacy England estimates there will be
Read moreNew positions have been created at Community Pharmacy England to increase our capacity for in-depth research and for LPC support, both of which are critical as we work to secure a sustainable future for community pharmacy. Experienced pharmacy leader and researcher Dr James Davies has been appointed as Director of Research and Insights at Community
Read moreBy Chief Executive Janet Morrison At Community Pharmacy England, work is continuing apace as we prepare for the next round of negotiations on the Community Pharmacy Contractual Framework (CPCF) and explore the implications of the NHS 10 Year Plan. Financial and economic analysis showing the depth of the ongoing funding crisis and the impact it
Read moreFollowing representations from Community Pharmacy England, the Department of Health and Social Care (DHSC) has re-determined that the following products will be granted special container status from 1 October 2025. Generic drug name (dm+d descriptor) Brand and/or Manufacturer Pack size Special container Cetrimide 0.2% / Benzalkonium chloride 0.01% cream Drapolene cream (Supra Enterprises Ltd) 200
Read moreCommunity Pharmacy England on behalf of pharmacy owners made further applications to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA), resulting in a further 43 new products being added to the ‘Drugs for which Discount is Not Deducted’ (DND) list from 1 October 2025. This takes the total
Read moreThe Department of Health and Social Care (DHSC) has today (26/09/2025) confirmed the following list of price concessions for September 2025: Drug Pack size Price concession Acetazolamide 250mg tablets 112 £31.50 Bumetanide 1mg tablets 28 £2.75 Buprenorphine 2mg sublingual tablets sugar free 7 £1.62 Buprenorphine 8mg sublingual tablets sugar free 7 £4.19 Carbocisteine 250mg/5ml oral solution 300 £4.88
Read moreThe Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 October2025. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item requiring reconstitution –
Read morePharmacy press As today marks World Pharmacists Day, an annual awareness day led by the International Pharmaceutical Federation (FIP), we’re celebrating the vital role pharmacists play in improving healthcare access and supporting communities across the country. We shared the statement below with the pharmacy press. Janet Morrison, Chief Executive of Community Pharmacy England, said: “On
Read moreThe Department of Health and Social Care (DHSC) has today (23/09/2025) confirmed the following list of price concessions for September 2025: Drug Pack size Price concession Amiodarone 200mg tablets 28 £5.97 Co-careldopa 25mg/100mg tablets 100 £8.38 Co-codamol 30mg/500mg tablets 30 £1.23 Co-codamol 30mg/500mg tablets 100 £4.10 Esomeprazole 20mg gastro-resistant capsules 28 £4.95 Fenofibrate micronised 267mg capsules 28 £5.80
Read more
